2022 IUA立场声明:无选择性慢性肢体威胁性缺血

2022-10-01 国际血管联盟 Int Angiol 发表于安徽省

由于人口老龄化和糖尿病的全球流行,外周动脉疾病的发病率有所增加。部分患者发展为慢性威胁肢体缺血。本文主要介绍了介绍无选择性慢性肢体威胁性缺血患者的管理,包括伤口治疗和康复,始终考虑到提高患者生活质量的

中文标题:

2022 IUA立场声明:无选择性慢性肢体威胁性缺血

英文标题:

International Union of Angiology Position Statement on no-option chronic limb threatening ischemia

发布机构:

国际血管联盟

发布日期:

2022-10-01

简要介绍:

由于人口老龄化和糖尿病的全球流行,外周动脉疾病的发病率有所增加。部分患者发展为慢性肢体威胁性缺血。本文主要介绍了介绍无选择性慢性肢体威胁性缺血患者的管理,包括伤口治疗和康复,始终考虑到提高患者生活质量的目标。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 IUA立场声明:无选择性慢性肢体威胁性缺血.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e72171c002989013, title=2022 IUA立场声明:无选择性慢性肢体威胁性缺血, enTitle=International Union of Angiology Position Statement on no-option chronic limb threatening ischemia, guiderFrom=Int Angiol, authorId=0, author=, summary=由于人口老龄化和糖尿病的全球流行,外周动脉疾病的发病率有所增加。部分患者发展为慢性威胁肢体缺血。本文主要介绍了介绍无选择性慢性肢体威胁性缺血患者的管理,包括伤口治疗和康复,始终考虑到提高患者生活质量的, cover=https://img.medsci.cn/Random/doctor-writing-prescription-or-medical-PDEMCBW.jpg, journalId=0, articlesId=null, associationId=1013, associationName=国际血管联盟, associationIntro=国际血管联盟(International Union of Angiology, IUA),创建于1950年。这是一个以血管外科医师为主导的血管相关学科医师参与的大型国际学术组织。目前拥有73个国家的数千名会员,每2年在世界各地召开国际学术活动,积极开展相关的学术交流。, copyright=0, guiderPublishedTime=Sat Oct 01 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #333333;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>由于人口老龄化和糖尿病的全球流行,外周动脉疾病的发病率有所增加。部分患者发展为慢性肢体威胁性缺血。本文主要介绍了介绍无选择性慢性肢体威胁性缺血患者的管理,包括伤口治疗和康复,始终考虑到提高患者生活质量的目标。</p> </div> </div> </div> <div class="box_info" style="color: #333333;">&nbsp;</div>, tagList=[TagDto(tagId=121335, tagName=慢性肢体威胁性缺血)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=121335, articleKeyword=慢性肢体威胁性缺血, articleKeywordNum=6, guiderKeywordId=121335, guiderKeyword=慢性肢体威胁性缺血, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9899, appHits=26, showAppHits=0, pcHits=99, showPcHits=9873, likes=0, shares=3, comments=3, approvalStatus=1, publishedTime=Thu Feb 23 16:46:00 CST 2023, publishedTimeString=2022-10-01, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Feb 17 13:52:07 CST 2023, updatedBy=2427819, updatedName=梁丽玲, updatedTime=Fri Jan 05 13:48:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=安徽省, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 IUA立场声明:无选择性慢性肢体威胁性缺血.pdf)])
2022 IUA立场声明:无选择性慢性肢体威胁性缺血.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2116183, encodeId=91a22116183e8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Thu Feb 23 22:09:12 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116340, encodeId=189a21163409e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Feb 24 21:11:30 CST 2023, time=2023-02-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116184, encodeId=8525211618417, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Thu Feb 23 22:09:35 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省)]
    2023-02-23 1243a20em71(暂无昵称) 来自山东省

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2116183, encodeId=91a22116183e8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Thu Feb 23 22:09:12 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116340, encodeId=189a21163409e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Feb 24 21:11:30 CST 2023, time=2023-02-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116184, encodeId=8525211618417, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Thu Feb 23 22:09:35 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省)]
    2023-02-24 1243a20em71(暂无昵称) 来自山东省

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2116183, encodeId=91a22116183e8, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Thu Feb 23 22:09:12 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116340, encodeId=189a21163409e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Fri Feb 24 21:11:30 CST 2023, time=2023-02-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2116184, encodeId=8525211618417, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d222471257, createdName=1243a20em71(暂无昵称), createdTime=Thu Feb 23 22:09:35 CST 2023, time=2023-02-23, status=1, ipAttribution=山东省)]
    2023-02-23 1243a20em71(暂无昵称) 来自山东省

    学习学习

    0

拓展阅读

AHA 2022:手术是防止腿部循环不良的人截肢的最佳方法(BEST-CLI研究)

在美国心脏协会 2022 年科学会议上提出的最新研究,数据显示,与接受血管成形术和支架植入等微创手术的患者相比,接受搭桥手术以改善腿部和足部血流的严重外周动脉疾病或 PAD 患者的重复手术次数减少 6

NEJM:慢性肢体缺血的手术或血管内治疗(BEST-CLI研究)

800万-1000万美国人患有动脉闭塞性疾病,每年每100万人中有500-1000例慢性肢体缺血新发病例。慢性肢体威胁性缺血(chronic limb threatening ischemia,&nb

2022 NICE指南:慢性肢体威胁性缺血的浅静脉动脉化[IPG736]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2022-08-24